|
|
 |
|
Viewing report
|
|
|
|
Western European Market for Image-guided and Robot-assisted Surgery
Frost & Sullivan, Dec 2009, Pages: 104
This research service examines the Western European Image Guide and Robot Assisted Surgery market in terms of the challenges faced by market participants, drivers, and restraints in the industry, the market share analysis, the revenue forecasts and growth rates
This Frost & Sullivan research service titled Western European Market for Image-guided and Robot-assisted Surgery provides market drivers and restraints along with revenue forecasts and market share analysis of the image-guided surgery (IGS) and robot-assisted surgery (RAS) markets in western Europe. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: image-guided surgery, robot-assisted surgery, and robotic image navigation. The western European countries covered in this research are: Germany, France, the United Kingdom, Italy, Spain, Scandinavia and Benelux.
This analysis is available through Frost & Sullivan's Medical Devices Growth Partnership Services programme. With continuous access to intelligence and resources from all seven perspectives of the Complex Business Universe, the Growth Partnership Services programme ensures that you and your Growth Team™ are able to maintain a 360 Degree Perspective of the market. This comprehensive, objective information allows your company to mitigate risk, identify new opportunities, and drive effective strategies for growth.
Market Overview
The Global Trend towards Laparoscopic Surgery Spurs the Western European Market for IGS and RAS
There is a global trend towards minimally invasive procedures or laparoscopic procedures as they reduce risks and are more convenient compared to open surgery. Boosted by this trend, the western European market for IGS and RAS is a highly dynamic one. “Improving outcomes along with benefits for both health providers and patients fuels adoption of IGS and RAS systems, despite the high system costs and limited reimbursement,” says the analyst of this research service. “The IGS and RAS markets are mainly driven by technological advancements that improve accuracy and allow for better outcomes.”
IGS and RAS technologies are more precise, enhance outcomes and reduce the risk of damaging healthy tissues, paving the way for surgeons to make informed decisions and have a greater probability of avoiding errors. Additionally, since these technologies are minimally invasive, they lead to a shorter recovery time compared to traditional surgery. The healthcare systems in several developed countries are under the pressure to improve their quality despite significant financial constraints and shortage of clinical manpower. This pressure keeps increasing as the population gets older. Health providers aim to simultaneously reduce hospitalisation time as well improve the treatment quality. IGS and RAS systems improve accuracy, reduce recovery time and, in some cases, even diminish the number of clinical staff needed. Therefore, healthcare providers benefit from adopting these technologies both in terms of quality and costs.
Vendors to Make Clients Aware of the Benefits IGS and RAS Systems
The western European IGS and RAS markets could have been larger had the systems been less expensive or if there were suitable reimbursement policies in place. Although these systems save costs for the healthcare provider in the long term, they require a high capital investment. The burgeoning costs involved in purchasing, maintaining and using these systems, coupled with the lack of reimbursement, act as a significant barrier for adoption. “As the vast majority of IGS and RAS procedures are not reimbursed, hospitals need to invest in this expensive equipment from their own pocket and pay the ‘per procedure’ additional cost from the general procedure budget,” explains the analyst. “Several hospitals avoid investing in such high-priced systems due to budgetary constraints, resulting in a lower adoption rate for some of these technologies.”
Vendors should focus on making their clients aware of the benefits of the systems until such time when there is direct reimbursement for IGS and RAS systems in most western European countries. Demonstrating the return-on-investment (ROI) in the long term to potential clients, based on both comprehensive economic assessment and established clinical evidence, may support adoption. “Companies should demonstrate systems usage to their clients and highlight how it will actually reduce costs in the long-term, in addition to improving clinical outcomes and patient satisfaction,” concludes the analyst. “The vendor will be able to enhance adoption by indicating the cost effectiveness of the system to clients, based on established data.”
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
By Product Type:
- Image-guided surgery
- Robot-assisted surgery
- Robotic image navigation
By Region:
- Germany
- France
- The United Kingdom
- Italy
- Spain
- Scandinavia
- Benelux
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
U.S. Image Guided and Robot Assisted Surgery Markets
Computer Assisted Surgical (CAS) Systems - Global Strategic Business Report
Service Robotics - Global Strategic Business Report
European 3D Imaging Markets
Global Service Robotics Market (2010 - 1015)
Industrial Robotics - Global Strategic Business Report
European Molecular Imaging Markets
Spinal Surgery - Global Strategic Business Report
Snake Robots Market Shares, Strategies, and Forecasts, Worldwide 2011 to 2017
Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical – Global Trends & Competitive Analysis
|
|
|
|
